Related references
Note: Only part of the references are listed.The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
Yogesh B. Patil et al.
BIOMATERIALS (2010)
Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers
Daria Yu. Alakhova et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP
Xiaowei Dong et al.
CANCER RESEARCH (2009)
Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells
Andrea Kruehn et al.
CELL CYCLE (2009)
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Marian E. Gindy et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Drug Nanocarriers and Functional Nanoparticles: Applications in Cancer Therapy
Benjamin Thierry
Current Drug Delivery (2009)
Advances in lipid nanodispersions for parenteral drug delivery and targeting
Panaylotis P. Constantinides et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The use of GEM models for experimental cancer therapeutics
Aarthi Gopinathan et al.
DISEASE MODELS & MECHANISMS (2008)
Colloidal carriers for the enhanced delivery through the skin
D. Cosco et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Elena V. Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro and in vivo
Yuhong Ren et al.
MOLECULAR PHARMACEUTICS (2008)
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
Maha Saad et al.
NANOMEDICINE (2008)
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Ofra Benny et al.
NATURE BIOTECHNOLOGY (2008)
Multi-anticancer drugs encapsulated in the micelle: A novel chemotherapy to cancer
Peng Liu et al.
MEDICAL HYPOTHESES (2008)
New frontiers in nanotechnology for cancer treatment
Frank Alexis et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells
Gregory Gatouillat et al.
CANCER LETTERS (2007)
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Eric M. Pridgen et al.
NANOMEDICINE (2007)
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux
Mahesh D. Chavanpatil et al.
MOLECULAR PHARMACEUTICS (2007)
Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle
Ting-Fan Yang et al.
BIOMATERIALS (2007)
Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs:: In vitro/in vivo case studies
Panayiotis P. Constantinides et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Reversal of BCRP-mediated multidrug resistance by stable expression of small interfering RNAs
Hui Lv et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody
Katalin Goda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Role of anthracyclines in the era of targeted therapy
Hernan Cortes-Funes et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Dai Fukumura et al.
MICROVASCULAR RESEARCH (2007)
Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells
Fatemeh Nadali et al.
HEMATOLOGY (2007)
An ultrastructural study of microvascular inter-endothelial tight junctions in normal endometrium
Mary Karakotchian et al.
MICRON (2007)
In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein
Florian Foeger et al.
BIOMATERIALS (2006)
Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding
Anna Seelig et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux
Mahesh D. Chavanpatil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells
Ho Lun Wong et al.
PHARMACEUTICAL RESEARCH (2006)
The functions and structure of ABC transporters: Implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)
E. Teodori et al.
CURRENT DRUG TARGETS (2006)
Pharmacological strategies for overcoming multidrug resistance
S. Nobili et al.
CURRENT DRUG TARGETS (2006)
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats
Emmanuel Garcion et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice
X Li et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors
Joanna M. Koziara et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibiltion
A Lamprecht et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical. efflux transporters in Caco-2 cell monolayers
EM Collnot et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system
Ho Lun Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Enhanced anti proliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
Sanjeeb K. Sahoo et al.
MOLECULAR PHARMACEUTICS (2005)
Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux
TW Loo et al.
JOURNAL OF MEMBRANE BIOLOGY (2005)
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells
T Minko et al.
JOURNAL OF CONTROLLED RELEASE (2005)
In vitro cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells
JC Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo
L Barraud et al.
JOURNAL OF HEPATOLOGY (2005)
Colloidal carriers for ophthalmic drug delivery
RM Mainardes et al.
CURRENT DRUG TARGETS (2005)
Solid lipid nanoparticles as drug delivery systems
K Manjunath et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2005)
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
A Nori et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
K Bogman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Absorption, distribution, and excretion of DJ-927, a novel orally effective taxane, in mice, dogs, and monkeys
C Ono et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Distribution kinetics of a micelle-forming block copolymer Pluronic P85
EV Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Effect of pluronic p85 on ATPase activity of drug efflux transporters
EV Batrakova et al.
PHARMACEUTICAL RESEARCH (2004)
Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems
S Tamilvanan
PROGRESS IN LIPID RESEARCH (2004)
Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85
EV Batrakova et al.
PHARMACEUTICAL RESEARCH (2003)
Drug delivery and transport to solid tumors
SH Jang et al.
PHARMACEUTICAL RESEARCH (2003)
Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines
YI Lo
JOURNAL OF CONTROLLED RELEASE (2003)
DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo
M Shionoya et al.
CANCER SCIENCE (2003)
Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells
EV Batrakova et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Nanoparticles in cancer therapy and diagnosis
I Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Pluronic® block copolymers for overcoming drug resistance in cancer
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
BD Rege et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
DJ Booser et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Lymphatic metastasis in the absence of functional intratumor lymphatics
TP Padera et al.
SCIENCE (2002)
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer
E Rivera et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: Discovery of BMS-184476
TJ Altstadt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
EV Batrakova et al.
BRITISH JOURNAL OF CANCER (2001)
Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells
T Minko et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells
S Kawabata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Preclinical antitumor activity of two novel taxanes
WC Rose et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance
LD Mayer et al.
CANCER AND METASTASIS REVIEWS (2001)
Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors
KA Gelmon et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Stabilization of pluronic P-105 micelles with an interpenetrating network of N,N-diethylacrylamide
JD Pruitt et al.
MACROMOLECULES (2000)
Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
RH Müller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
HPMA copolymer-anticancer drug conjugates:: design, activity, and mechanism of action
J Kopecek et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx
T Yamazaki et al.
CANCER LETTERS (2000)
Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors
T Kurata et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
